is gastroparesis from glp-1 reversible Gastroparesis: Hidden Dangers Beyond C Gastroparesis (Stomach Paralysis): Symptoms; GLP-1

Consistently low protein intake increases the risk of muscle loss, weakness, hair thinning, and metabolic slowdown

Li J, Mooney DJ

SGLT-2 inhibitors act primarily in the renal proximal tubule and have no established direct actions on mesolimbic reward circuits in the brain.63 On the contrary, neurotropism is a distinct property of GLP-1 receptor agonists.62 GLP-1 is produced in the brain, GLP-1 receptors are present in areas of the brain involved in impulse control and reward signalling, and a pharmacologically administered exogenous GLP-1 receptor agonist crosses the blood-brain barrier and enters the brain within minutes, strengthening the inference that the observed GLP-1 receptor agonist anti-addictive properties are likely specific and biologically plausible drug effect of GLP-1 receptor agonism, distinct from the general benefits of treating diabetes that would be expected with both SGLT-2 inhibitors and GLP-1 receptor agonists.6465 These observational findings do not by themselves justify the prescribing of GLP-1 receptor agonists specifically to prevent or treat SUDs

sales (IQVIA MAT Aug 2025) making this entry both strategically and commercially significant

GLP-1 agonists commonly cause nausea, vomiting, diarrhea, and abdominal painsymptoms that overlap with Crohn's disease

August 3 doi: 10.1016/S0140-6736(17)31585-4